SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-24-006914
Filing Date
2024-05-07
Accepted
2024-05-07 07:57:14
Documents
62
Period of Report
2024-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q qure-20240331x10q.htm   iXBRL 10-Q 1646686
2 EX-31.1 qure-20240331xex31d1.htm EX-31.1 15049
3 EX-31.2 qure-20240331xex31d2.htm EX-31.2 15058
4 EX-32.1 qure-20240331xex32d1.htm EX-32.1 14739
  Complete submission text file 0001558370-24-006914.txt   6547628

Data Files

Seq Description Document Type Size
5 EX-101.SCH qure-20240331.xsd EX-101.SCH 41333
6 EX-101.CAL qure-20240331_cal.xml EX-101.CAL 47706
7 EX-101.DEF qure-20240331_def.xml EX-101.DEF 229659
8 EX-101.LAB qure-20240331_lab.xml EX-101.LAB 415014
9 EX-101.PRE qure-20240331_pre.xml EX-101.PRE 328945
66 EXTRACTED XBRL INSTANCE DOCUMENT qure-20240331x10q_htm.xml XML 981398
Mailing Address PAASHEUVELWEG 25A AMSTERDAM P7 1105 BP
Business Address PAASHEUVELWEG 25A AMSTERDAM P7 1105 BP 1-339-970-7000
uniQure N.V. (Filer) CIK: 0001590560 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36294 | Film No.: 24919674
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)